First published 10/3/2026, 9:00:15 PM · Last updated 10/3/2026, 9:00:15 PM

Treatment of Medullary Carcinoma of the Thyroid: Value of calcitonin as tumour marker

Journal article on treatment of medullary carcinoma of the thyroid reporting on the value of calcitonin as a tumour marker. Source metadata lists publisher and content type but provides no study details or results.

Illustrative image: Low magnification micrograph of medullary thyroid carcinoma , abbreviated MTC . H&E stain . MTC can be remembered by the 3 Ms: aMyloid . Median node dissection. MEN 2A & MEN 2B. It typically stains with: Calcitonin . CEA . Chromogranin A . Multiple endocrine neoplasia 2A: Medullary thyroid carcinoma. Parathyroid adenoma . Pheochromocytoma . Multiple endocrine neoplasia 2B: Medullary thyroid carcinoma. Pheochromocytoma. Neuromas/ganglioneuromas. Related images Low mag. Intermed. mag. High mag. In — Nephron/Wikimedia Commons, CC BY-SA 3.0

Categories: public-health, science-and-space

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 4/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 6/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

Identifies calcitonin's potential role as a diagnostic tumour marker for medullary thyroid carcinoma.

Sources

Treatment of Medullary Carcinoma of the Thyroid: Value of calcitonin as tumour markerMetadata provided by Crossref. Usage terms

Report an issue